Ann: Activities Statement and Appendix 4C, page-5

I must say that there is a slight patch of blue appearing amongst all the dark clouds with some market share being achieved for a product which is something new and might have a decent life.

I can only assume that the Testosterone generic has been a complete and utter flop as this product does not seem to be worth a mention? Unfortunately “they do not provide information on royalties broken down by product” or so I was told.

So things remain diabolical but just perhaps they may not have to reach into our collective pockets for more cash. So just the normal kick up the rear (that won’t be stopping) but no hand extending into the hip pocket for now!